Post by
Golddetector on Jun 01, 2021 8:58am
Reborn trials
This will be the big thing over the next few weeks. The dosing of 1st patient is starting this week and results and curves and comparisons against morphine will to show up in weeks to follow. It is a big ticket item. Morphine is currently dominating pain market. A more effective medicine won't pass unnoticed. I hope big pharma will give them room before someone jumps on and takeover this company. Big industry to protect here. Good luck long hold tight. Btw there is someone trying to short here he flooded the board when th useless messages. It reminds with the situation when sp was at 18 cents. In away it is a good indication.
Comment by
SamV21 on Jun 01, 2021 2:35pm
It took them a month to find 3 blind mice for their Phase one study, they don't even have all their patients for the testing , at the meeting on Friday they had one , they need 20 people and months of study and monitoring after the study for side effects. Its a blind study , we will be the last ones to know anything till the summary is done.